Testing effectiveness (Phase 2)Study completedNCT02573181
What this trial is testing
Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)
Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 253